Albendazole 10%
Product Description
Cipla Ltd
-
IN -
2015On CPHI since
Company types
Categories
Specifications
Cipla Ltd
-
IN
-
2015On CPHI since
Company types
More Products from Cipla Ltd (99)
-
Product Acyclovir 25 mg
Cipla Ltd offers wide range of formulation products which includes acyclovir 25 mg. Dosage form: infusion. Therapeutic area: antiinfectives. Packaging type: bottle. Contact us for more information. -
Product Acyclovir 250 mg
Cipla Ltd offers wide range of formulation products which includes acyclovir 250 mg. Dosage form: lyophilised injection. Therapeutic area: antiinfectives. Packaging type: vial. Contact us for more information. -
Product Acyclovir 3% w/w
Cipla Ltd offers wide range of formulation products which includes acyclovir 3% w/w. Dosage form: eye ointment. Therapeutic area: ophthalmic products. Packaging type: tube. Contact us for more information. -
Product Acyclovir 400 mg
Cipla Ltd offers wide range of formulation products which includes acyclovir 400 mg. Dosage form: dispersible tablet. Therapeutic area: antiinfectives. Packaging type: blister. Contact us for more information. -
Product Acyclovir 800 mg
Cipla Ltd offers wide range of formulation products which includes acyclovir 800 mg. Dosage form: dispersible tablet. Therapeutic area: antiinfectives. Packaging type: blister. Contact us for more information. -
Product Adefovir dipivoxil 10 mg
Cipla Ltd offers wide range of formulation products which includes adefovir dipivoxil 10 mg. Dosage form: tablets. Therapeutic area: antiinfectives. Packaging type: container. Contact us for more information. -
Product Albendazole 1000 mg
Cipla Ltd offers wide range of formulation products which includes albendazole 1000 mg. Dosage form: bolus. Contact us for more information. -
Product Albendazole 1500 mg
Cipla Ltd offers wide range of formulation products which includes albendazole 1500 mg. Dosage form: bolus. Contact us for more information. -
Product Albendazole 2.5%
Cipla Ltd offers wide range of formulation products which includes albendazole 2.5%. Dosage form: suspension. Contact us for more information. -
Product Albendazole 20 mg/ml
Cipla Ltd offers wide range of formulation products which includes albendazole 20 mg/ml. Dosage form: oral suspension. Therapeutic area: antiinfectives. Packaging type: bottle. Contact us for more information. -
Product Albendazole 200 mg
Cipla Ltd offers wide range of formulation products which includes albendazole 200 mg. Dosage form: oral suspension. Therapeutic area: antiinfectives. Packaging type: bottle. Contact us for more information. -
Product Albendazole 250 mg
Cipla Ltd offers wide range of formulation products which includes albendazole 250 mg. Dosage form: bolus. Contact us for more information.
Cipla Ltd resources (1)
-
News Cipla and Kemwell to form joint venture targeting respiratory biosimilars market
The agreement is expected to accelerate Cipla’s global lung leadership agenda
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance